Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P30044 (
antioxidant enzyme
)
8,037
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nuclear receptor-binding SET domain-containing protein 1
(
NSD1
) has been proved to act as a histone methyltransferase and a transcription co-factor to regulate gene expression. However, the role of
NSD1
in oxidative stress remains poorly understood. In the present study, we focused on the
NSD1
regulation of
antioxidant enzyme
gene glutathione S-transferase M3 (GSTM3) expression in response to oxidative stress. H2O2 treatment caused the decrease of both
NSD1
and GSTM3 expression, and the depletion of
NSD1
expression by specific siRNA reversed the H2O2-reduced GSTM3 expression. Furthermore, we investigated
NSD1
modulating the transcription of GSTM3 promoter with -63A/C polymorphism closed to TATA box in response to H2O2 by luciferase and in vitro or in vivo DNA-protein binding assays. The promoter activity of GSTM3 with -63A was higher than -63C, and was increased or decreased by the overexpression or depletion of
NSD1
, but -63C was not influenced. H2O2 repressed the promoter activity of GSTM3 with -63A more than -63C, and the depletion of
NSD1
expression weakened H2O2 inhibition on the -63A promoter, but augmented H2O2 inhibition on the -63C promoter. In addition,
NSD1
interacted with RNAPII and bound to GSTM3 -63A/C TATA box, with higher binding affinity to -63A than to -63C. These data indicated that
NSD1
implicated in H2O2-induced oxidative stress, and H2O2-induced
NSD1
suppression resulted in the decrease of GSTM3 expression through the -63A/C TATA box.
...
PMID:Role of NSD1 in H2O2-induced GSTM3 suppression. 2519 15